Overview
No overview information available.
Background
No background information available.
Indication
用于治疗高胆固醇血症和纯合子型家族性高胆固醇血症(HoFH)。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Ezetimibe and Atorvastatin Calcium Tablets（Ⅰ） | 国药准字H20253268 | 化学药品 | 片剂 | 1/24/2025 | |
| Ezetimibe and Atorvastatin Calcium Tablets（Ⅰ） | 国药准字HJ20230109 | 化学药品 | 片剂 | 9/12/2023 | |
| Ezetimibe and Atorvastatin Calcium Tablets（Ⅱ） | 国药准字H20253380 | 化学药品 | 片剂 | 2/11/2025 | |
| Ezetimibe and Atorvastatin Calcium Tablets（Ⅱ） | 国药准字H20253267 | 化学药品 | 片剂 | 1/24/2025 | |
| Ezetimibe and Atorvastatin Calcium Tablets（Ⅱ） | 国药准字HJ20230110 | 化学药品 | 片剂 | 9/12/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||